Kingworld's Associate Enters Research Agreement for Two Products with Hospital

Stock News06-11

KINGWORLD (HKEX: 01110) has announced that on June 11, 2026, its connected person, Jin Chen Pharmaceutical Co., Ltd., entered into a memorandum of understanding with Dongguan Hospital of Guangzhou University of Chinese Medicine regarding the research and development of two products.

The products in question are "Zi Zhu Ye Lotion" and "Jia Wei Tian Ma Jian Nao Formula." The parties intend to collaborate on the clinical research, regulatory registration, and commercialization of these products.

On the same date, the company's connected person, Jin Chen, also entered into a memorandum of understanding with KINGWORLD. Under this agreement, Jin Chen intends to appoint KINGWORLD and/or its wholly-owned subsidiary as the sole and exclusive distributor for the two products.

The proposed distribution arrangement will cover the distribution of "Zi Zhu Ye Lotion" and "Jia Wei Tian Ma Jian Nao Formula" in the markets of Hong Kong, mainland China, and through cross-border e-commerce channels.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166913637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 20:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166913637","market":"sg","top_or_hot":-1,"title":"Kingworld's Associate Enters Research Agreement for Two Products with Hospital","media":"Stock News","content":"<p><b>KINGWORLD</b> (HKEX: 01110) has announced that on June 11, 2026, its connected person, Jin Chen Pharmaceutical Co., Ltd., entered into a memorandum of understanding with Dongguan Hospital of Guangzhou University of Chinese Medicine regarding the research and development of two products.<br><br>The products in question are \"Zi Zhu Ye Lotion\" and \"Jia Wei Tian Ma Jian Nao Formula.\" The parties intend to collaborate on the clinical research, regulatory registration, and commercialization of these products.<br><br>On the same date, the company's connected person, Jin Chen, also entered into a memorandum of understanding with <b>KINGWORLD</b>. Under this agreement, Jin Chen intends to appoint <b>KINGWORLD</b> and/or its wholly-owned subsidiary as the sole and exclusive distributor for the two products.<br><br>The proposed distribution arrangement will cover the distribution of \"Zi Zhu Ye Lotion\" and \"Jia Wei Tian Ma Jian Nao Formula\" in the markets of Hong Kong, mainland China, and through cross-border e-commerce channels.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kingworld's Associate Enters Research Agreement for Two Products with Hospital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKingworld's Associate Enters Research Agreement for Two Products with Hospital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-11 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>KINGWORLD</b> (HKEX: 01110) has announced that on June 11, 2026, its connected person, Jin Chen Pharmaceutical Co., Ltd., entered into a memorandum of understanding with Dongguan Hospital of Guangzhou University of Chinese Medicine regarding the research and development of two products.<br><br>The products in question are \"Zi Zhu Ye Lotion\" and \"Jia Wei Tian Ma Jian Nao Formula.\" The parties intend to collaborate on the clinical research, regulatory registration, and commercialization of these products.<br><br>On the same date, the company's connected person, Jin Chen, also entered into a memorandum of understanding with <b>KINGWORLD</b>. Under this agreement, Jin Chen intends to appoint <b>KINGWORLD</b> and/or its wholly-owned subsidiary as the sole and exclusive distributor for the two products.<br><br>The proposed distribution arrangement will cover the distribution of \"Zi Zhu Ye Lotion\" and \"Jia Wei Tian Ma Jian Nao Formula\" in the markets of Hong Kong, mainland China, and through cross-border e-commerce channels.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1166913637","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166913637","pubTimestamp":1781179593,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"KINGWORLD (HKEX: 01110) has announced that on June 11, 2026, its connected person, Jin Chen Pharmaceutical Co., Ltd., entered into a memorandum of understanding with Dongguan Hospital of Guangzhou...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1574":"生物医药B类股","BK1515":"抗疫概念","01110":"金活医药集团","BK1197":"保健护理产品经销商","09939":"开拓药业-B","BK1161":"生物科技"},"translate_title":"金活联营公司与医院签订两种产品研究协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"01110":1,"09939":1},"content_text":"KINGWORLD (HKEX: 01110) has announced that on June 11, 2026, its connected person, Jin Chen Pharmaceutical Co., Ltd., entered into a memorandum of understanding with Dongguan Hospital of Guangzhou University of Chinese Medicine regarding the research and development of two products.The products in question are \"Zi Zhu Ye Lotion\" and \"Jia Wei Tian Ma Jian Nao Formula.\" The parties intend to collaborate on the clinical research, regulatory registration, and commercialization of these products.On the same date, the company's connected person, Jin Chen, also entered into a memorandum of understanding with KINGWORLD. Under this agreement, Jin Chen intends to appoint KINGWORLD and/or its wholly-owned subsidiary as the sole and exclusive distributor for the two products.The proposed distribution arrangement will cover the distribution of \"Zi Zhu Ye Lotion\" and \"Jia Wei Tian Ma Jian Nao Formula\" in the markets of Hong Kong, mainland China, and through cross-border e-commerce channels.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166913637","isCrawlerRequest":true}